Targeted regulation of miR-195 on MAP2K1 for suppressing ADM drug resistance in prostate cancer cells.
- DOI
- 10.26355/eurrev_201812_16623
- Published
- 2018 Dec
- Container
- European review for medical and pharmacological sciences
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.26355/eurrev_201812_16623,
title = {Targeted regulation of miR-195 on MAP2K1 for suppressing ADM drug resistance in prostate cancer cells.},
author = {Zhang JY and Li YN and Mu X and Pan ZL and Liu WB},
year = {2018},
journal = {European review for medical and pharmacological sciences},
doi = {10.26355/eurrev_201812_16623},
url = {https://doi.org/10.26355/eurrev_201812_16623}
}RIS
TY - JOUR TI - Targeted regulation of miR-195 on MAP2K1 for suppressing ADM drug resistance in prostate cancer cells. AU - Zhang JY AU - Li YN AU - Mu X AU - Pan ZL AU - Liu WB PY - 2018 JO - European review for medical and pharmacological sciences DO - 10.26355/eurrev_201812_16623 UR - https://doi.org/10.26355/eurrev_201812_16623 ER -
APA
JY, Z., YN, L., X, M., ZL, P., & WB, L. (2018). Targeted regulation of miR-195 on MAP2K1 for suppressing ADM drug resistance in prostate cancer cells.. European review for medical and pharmacological sciences. https://doi.org/10.26355/eurrev_201812_16623
Source records
- pubmed · retrieved 2026-11-10T09:33:10.802Z